PEA vs. Boswellia (Frankincense Extract) for Joint Inflammation: An Evidence-Based Comparison
PEA vs boswellia for joint inflammation: what the evidence supports for each, how the two compare fairly, and why some products combine them.
Benefits And Science
PEA and Luteolin Together: Why This Combination Keeps Appearing in Research and Products
Why PEA and luteolin keep appearing together: what luteolin adds, the post-COVID olfactory and stroke rehabilitation data, and where it does not apply.
PEA for Dental Pain and TMJ: What the Nerve Pain and Anti-Inflammatory Research Suggests
What the human trial on PEA for TMJ pain found, what animal research adds, and how the nerve pain evidence applies to dental pain more broadly.
PEA for Chemotherapy-Induced Peripheral Neuropathy (CIPN): What Cancer Patients Should Know
PEA for chemotherapy-induced neuropathy: a promising 2011 pilot, a 2024 phase II trial with a different result, and what cancer patients should know.
PEA for Sciatica: Can Palmitoylethanolamide Help With Nerve Root Pain?
What the sciatica evidence for PEA rests on: a post hoc reanalysis, newer delivery research, and how it differs from PEA’s other pain evidence.
Palmitoylethanolamide and Sleep Quality: What Pain-Sleep Research Suggests
Explore how PEA (palmitoylethanolamide) may support sleep quality by reducing pain and neuroinflammation. Evidence-based, honest review.
Palmitoylethanolamide and PPAR-α: The Molecular Switch Behind Its Anti-Inflammatory Action
Learn how PEA activates the PPAR-α nuclear receptor to reduce inflammation and pain—what the science shows and what it means for supplementation.
PEA for Osteoarthritis: Joint Pain Support Without the Long-Term Risks of NSAIDs
How palmitoylethanolamide (PEA) may support knee osteoarthritis pain without NSAID risks—mechanism, clinical evidence, and honest caveats.
Palmitoylethanolamide for Neuropathic Pain: A Review of Human Randomized Controlled Trials
An evidence-based review of human RCTs on palmitoylethanolamide (PEA) for neuropathic pain — mechanism, clinical findings, formulations, and safety.
Palmitoylethanolamide and Multiple Sclerosis: What the Evidence Shows About Neuroinflammation and Neuropathic Pain
PEA is an endogenous fatty acid amide studied for neuroinflammation and pain in multiple sclerosis. Here is what current evidence shows.
PEA for Migraine and Chronic Headache: What the Early Clinical Research Shows
Palmitoylethanolamide (PEA) is being studied for migraine prevention. Here’s an honest look at the proposed mechanism and early clinical findings.
Palmitoylethanolamide (PEA) for Long COVID: Neuroinflammation, Brain Fog, and Post-Viral Pain
Explore the clinical evidence on palmitoylethanolamide (PEA) for long COVID symptoms including brain fog, olfactory loss, fatigue, and post-viral pain.